IF: 0.644
REUTERS THOMSON

Thrombotic Microangiopathy in IgA Nephropathy

AUTHORS

Hamid Nasri 1 , *

AUTHORS INFORMATION

1 Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, IR Iran

How to Cite: Nasri H. Thrombotic Microangiopathy in IgA Nephropathy, Iran Red Crescent Med J. 2013 ; 15(12):e10234. doi: 10.5812/ircmj.10234.

ARTICLE INFORMATION

Iranian Red Crescent Medical Journal: 15 (12); e10234
Published Online: December 5, 2013
Article Type: Letter
Received: January 11, 2013
Revised: January 14, 2013
Accepted: May 15, 2013
Crossmark

Crossmark

CHEKING

READ FULL TEXT

Keywords

Thrombosis Thrombotic Microangiopathies Nephropathy

Copyright © 2013, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Dear Editor,

Thrombotic microangiopathy (TMA) occurs in IgA nephropathy, but is uncommon in the setting of IgA nephropathy. Recently an article published by El Karoui and colleagues, entitled “A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy” (1). They retrospectively examined a series of 128 patients diagnosed with IgA nephropathy (IgAN) between 2002 and 2008 who had a mean follow-up of 44 ± 27 months. They found that, 53 % presented with lesions of thrombotic microangiopathy (TMA), acute or organized, in arteries and / or arterioles. They concluded that, lesions of TMA are frequent in IgA nephropathy and may occur in normotensive patients with near-normal renal histology (1). However, we would like to remind a few points about TMA in IgA nephropathy. In a study on 102 primary IgA nephropathy patients, we found, morphologic lesions of TMA in 2 % of our patients, while all of them had malignant hypertension (2). In our study 71.6 % of patients were male. The mean age of the patients was 37.7 years. Morphologic variables of MEST classification was as follows; M1: 90.2 %, E: 32 %, S: 67 % also in grads I and II were in 30 % and 19 % respectively, while 51 % were in grade zero. Previously in a study on a small group of IgAN patients with thrombotic microangiopathy injury, Chang et al. (3) found, association of TMA with advanced stages and severe proteinuria of IgA nephropathy. Few publications existed regarding the TMA in IgA nephropathy. However, it is uncommon in the setting of IgA nephropathy and its significance, as a concomitant histologic finding, is unclear (4, 5). It is possible that IgAN has different presentation between different regions (6-8). However, the reports of overlapping morphologic lesions of TMA and IgAN are poorly understood and debatable and needs more attention in larger series of IgAN (8-10).

Acknowledgements

Footnotes

References

  • 1. El Karoui K, Hill GS, Karras A, Jacquot C, Moulonguet L, Kourilsky O, et al. A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol. 2012; 23(1) : 137 -48 [DOI][PubMed]
  • 2. Nasri H, Mortazavi M, Ghorbani A, Shahbazian H, Kheiri S, Baradaran A, et al. Oxford-MEST classification in IgA nephropathy patients: A report from Iran. J Nephropathol. 2012; 1(1) : 31 -42 [DOI]
  • 3. Chang A, Kowalewska J, Smith KD, Nicosia RF, Alpers CE. A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy. Clin Nephrol. 2006; 66(6) : 397 -404
  • 4. Mubarak M. Oxford classification of IgA nephropathy: Broadening the scope of the classification. J Nephropathol. 2012; 1(1) : 13 -16 [DOI]
  • 5. Pipili C, Pantelias K, Papaioannou N, Paraskevakou H, Grapsa E. Hemolytic-uremic syndrome, malignant hypertension and IgA nephropathy: successful treatment with plasma exchange therapy. Transfus Apher Sci. 2012; 47(2) : 155 -8 [DOI][PubMed]
  • 6. Ibrahim Seif E, Abdel-Salam Ibrahim E, Galal Elhefnawy N, Ibrahim Salman M. Histological patterns of idiopathic steroid resistant nephrotic syndrome in Egyptian children: A single centre study. J Nephropathol. 2013; 2(1) : 53 -60 [DOI]
  • 7. Shakeel S, Mubarak M, Kazi IJ, Jafry N, Ahmed E. Frequency and clinicopathological characteristics of variants of primary focal segmental glomerulosclerosis in adults presenting with nephrotic syndrome. J Nephropathol. 2013; 2(1) : 28 -35 [DOI]
  • 8. Assadi F. The epidemic of pediatric chronic kidney disease: the danger of skepticism. J Nephropathol. 2012; 1(2) : 61 -64 [DOI]
  • 9. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol. 2012; 1(3) : 162 -163 [DOI]
  • 10. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic kidney disease in children: A report from a tertiary care center over 11 years. J Nephropathol. 2012; 1(3) : 177 -182 [DOI]
  • COMMENTS

    LEAVE A COMMENT HERE: